SCHEMBL6633352

SCHEMBL6633352

CCOC(=O)Cn1c(C(O)c2ccc(C#N)cc2)nc2ccc(N)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
KDM4E B2RXH2 3/20 0.39
HSD17B10 Q99714 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
HTT P42858 1/20 0.38
MAPT P10636 3/20 0.37
MEN1 O00255 1/20 0.37
MAPK1 P28482 1/20 0.37
KMT2A Q03164 1/20 0.37
POLB P06746 1/20 0.37
CYP11B2 P19099 2/20 0.37
CNR2 P34972 1/20 0.36
SHMT2 P34897 1/20 0.36
CYP11B1 P15538 1/20 0.36
TNF P01375 1/20 0.36
S1PR1 P21453 1/20 0.36
ACSS2 Q9NR19 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6636068 0.93 CNR2 (0.42) LMNANPSR1KDM4EHSD17B10TDP1
SCHEMBL6639700 0.85 IRAK4 (0.44) LMNANPSR1KDM4EALDH1A1MAPT
SCHEMBL6633288 0.81 PER2 (0.37) LMNANPSR1KDM4EHSD17B10TDP1
SCHEMBL6635529 0.81 BRPF1 (0.45) NPSR1ALDH1A1MEN1KMT2AS1PR1
SCHEMBL6634209 0.80 KMT2A (0.46) LMNAKDM4ETDP1ALDH1A1MAPT
SCHEMBL6633348 0.80 PPARG (0.48) NPSR1KDM4EHSD17B10TDP1ALDH1A1
SCHEMBL6634425 0.78 HCRTR2 (0.39) LMNANPSR1KDM4EHSD17B10TDP1
SCHEMBL6635791 0.76 CNR2 (0.40) LMNACNR2S1PR1
SCHEMBL6635874 0.76 BRPF1 (0.47) LMNANPSR1ALDH1A1MEN1KMT2A
SCHEMBL6639199 0.73 HCRTR2 (0.39) LMNANPSR1KDM4EHSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100795-B1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2004-06-09 EP disclosed
EP-1100795-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM ZENTRALE GMBH (DE) 2001-05-23 EP disclosed
US-6121308-A INDOLE AND BENZIMIDAZOLE ANTITHROMBOTIC COMPOUNDS, SUCH AS 1-METHYL-2-(N-(4-AMIDINOPHENYL)-AMINOMETHYL)-5-(N-(HYDROXYCARBONYLMETHYL) -QUINOLINE-8-SULPHONYLAMINO)-INDOLE BOEHRINGER INGELHEIM KG (DE) 2000-09-19 US disclosed
WO-2000008014-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-02-17 WO disclosed